Evaluating URMC's Massive Transfusion Protocol (MTP-TEG)

University of Rochester

Status: Completed

Conditions: Trauma; Acute Coagulopathy; Blood Coagulation Disorders

Treatments: Other: Blood collection

Study type: Observational

Funder types: Other

Identifiers

NCT02083549

UR- MTP-TEG

Details and patient eligibility

About

The purpose of the study is to evaluate the efficacy of the University of Rochester Medical Center's current Massive Transfusion Protocol.

Upon arrival of trauma level one designated patients the treating team evaluates the patient's injuries. If the patient is initiated under the facilities Massive Transfusion Protocol and meets other inclusion and exclusion criteria the patient will be enrolled in the study. Study procedures include collection of a blood sample following the transfusion of each shipment, through shipment 5, of blood products outlined in the current Massive Transfusion Protocol.

Each blood sample will be run on a Thromboelastograph to evaluate the patient's hematostatic state through resuscitation. One final blood sample will be collected 24 hours following the discontinuation of the Massive Transfusion Protocol and also ran on the thromboelastograph.

Due to the critical need for medical intervention, consent procedure will be waived at time of enrollment. An authorized representative for the patient will be identified and approached to obtain consent for use of data collected.

Enrollment: 2 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Trauma level 1 patient initiated under Massive Transfusion Protocol
• Age greater than or equal to 18 years old

Exclusion criteria

• Females who are pregnant

Trial design

2 participants in 1 patient group

Trauma 1 massively transfused

Description:

Trauma 1 massively transfused patients are identified as a Trauma level one patient by triage through guidelines from the Kessler Regional Trauma Center Trauma Triage Guidelines.

Treatment:

Other: Blood collection